Heat Biologics (HTBX) – Research Analysts' Recent Ratings Updates

Heat Biologics (HTBX) – Research Analysts' Recent Ratings Updates

The Company's products under development include HS-110 for the treatment of non-small cell lung cancer, HS-410 for the bladder cancer treatment, HS-310 to treat ovarian cancer and HS-510 for treating triple negative breast cancer. Heat Biologics, Inc

(Visited 1 times, 1 visits today)
5
Like
Save

Comments

Comments are disabled for this post.